Mirae Asset Global Etfs Holdings Ltd. Theravance Biopharma, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 39,046 shares of TBPH stock, worth $562,652. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,046
Previous 40,343
3.21%
Holding current value
$562,652
Previous $360,000
19.44%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TBPH
# of Institutions
138Shares Held
48.1MCall Options Held
0Put Options Held
11.6K-
Madison Avenue Partners, LP New York, NY9.51MShares$137 Million11.23% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$107 Million1.24% of portfolio
-
Newtyn Management, LLC New York, NY4.95MShares$71.3 Million10.56% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$54.5 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$39.8 Million4.49% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $962M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...